Bicycle Therapeutics BCYC
NASDAQ BCYC
$3.42 -0.13 (-3.79%)
As of: Oct 2, 2026 · 1:55 PM EDT

Bicycle Therapeutics (BCYC) Depreciation & Amortization (CF) (2018 - 2026)

Updated

Bicycle Therapeutics' Depreciation & Amortization (CF) was $1.07 million in Q2 2026, down 37.1% from $1.7 million a year earlier and down 5.5% from the prior quarter.

Analysis

Bicycle Therapeutics (BCYC) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, Bicycle Therapeutics' Depreciation & Amortization (CF) was $5.29 million through Jun 30, 2026, down 26.6% year-over-year; for FY2025, it came in at $6.42 million, down 10.5% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 38.1% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $7.17 million in FY2024 (+9.6%), $6.55 million in FY2023 (+77.4%), $3.69 million in FY2022 (+161.8%) and $1.41 million in FY2021 (+10.3%).
  • The Q2 2026 figure marks the lowest quarterly Depreciation & Amortization (CF) since Q2 2022.
  • Compared with a year earlier, Depreciation & Amortization (CF) has declined for four straight quarters, with an average decline of 9.4% over the last eight quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q3 2022 (growth of 275.1%); the worst was Q2 2026 (a decline of 37.1%).
  • Per Business Quant data, BCYC's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $1.13 million (Q1 2026), $1.34 million (Q4 2025) and $1.76 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Bicycle Therapeutics 256.92 Mn 256.92 Mn - 1.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.07 Mn
Mar 31, 2026 1.13 Mn
Dec 31, 2025 1.34 Mn
Sep 30, 2025 1.76 Mn
Jun 30, 2025 1.70 Mn
Mar 31, 2025 1.63 Mn
Dec 31, 2024 1.70 Mn
Sep 30, 2024 2.17 Mn
Jun 30, 2024 1.64 Mn
Mar 31, 2024 1.66 Mn
Dec 31, 2023 1.65 Mn
Sep 30, 2023 1.69 Mn
Jun 30, 2023 1.65 Mn
Mar 31, 2023 1.56 Mn
Dec 31, 2022 1.39 Mn
Sep 30, 2022 1.26 Mn
Jun 30, 2022 617,000.00
Mar 31, 2022 422,000.00
Dec 31, 2021 407,000.00
Sep 30, 2021 337,000.00
API Access

Bicycle Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=BCYC&period=max&api_key=YOUR_API_KEY